Global Glucagon Like Peptide 2 Receptor Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Glucagon Like Peptide 2 Receptor market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The Global Info Research report includes an overview of the development of the Glucagon Like Peptide 2 Receptor industry chain, the market status of Short Bowel Syndrome (FE-203799, Glepaglutide), Diabetes (FE-203799, Glepaglutide), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Glucagon Like Peptide 2 Receptor.

Regionally, the report analyzes the Glucagon Like Peptide 2 Receptor markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Glucagon Like Peptide 2 Receptor market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Glucagon Like Peptide 2 Receptor market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Glucagon Like Peptide 2 Receptor industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., FE-203799, Glepaglutide).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Glucagon Like Peptide 2 Receptor market.

Regional Analysis: The report involves examining the Glucagon Like Peptide 2 Receptor market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Glucagon Like Peptide 2 Receptor market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Glucagon Like Peptide 2 Receptor:
Company Analysis: Report covers individual Glucagon Like Peptide 2 Receptor manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Glucagon Like Peptide 2 Receptor This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Short Bowel Syndrome, Diabetes).

Technology Analysis: Report covers specific technologies relevant to Glucagon Like Peptide 2 Receptor. It assesses the current state, advancements, and potential future developments in Glucagon Like Peptide 2 Receptor areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Glucagon Like Peptide 2 Receptor market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Glucagon Like Peptide 2 Receptor market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    FE-203799
    Glepaglutide
    GXG-8
    HM-15910
    Others

Market segment by Application
    Short Bowel Syndrome
    Diabetes
    Diarrhea
    Obesity
    Others

Major players covered
    Hanmi Pharmaceuticals Co Ltd
    Naia Ltd
    Takeda
    Tasly Pharmaceutical Group Co Ltd
    Zealand Pharma AS

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon Like Peptide 2 Receptor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon Like Peptide 2 Receptor, with price, sales, revenue and global market share of Glucagon Like Peptide 2 Receptor from 2019 to 2024.
Chapter 3, the Glucagon Like Peptide 2 Receptor competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Like Peptide 2 Receptor breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Glucagon Like Peptide 2 Receptor market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon Like Peptide 2 Receptor.
Chapter 14 and 15, to describe Glucagon Like Peptide 2 Receptor sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Glucagon Like Peptide 2 Receptor
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Glucagon Like Peptide 2 Receptor Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 FE-203799
        1.3.3 Glepaglutide
        1.3.4 GXG-8
        1.3.5 HM-15910
        1.3.6 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Glucagon Like Peptide 2 Receptor Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Short Bowel Syndrome
        1.4.3 Diabetes
        1.4.4 Diarrhea
        1.4.5 Obesity
        1.4.6 Others
    1.5 Global Glucagon Like Peptide 2 Receptor Market Size & Forecast
        1.5.1 Global Glucagon Like Peptide 2 Receptor Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Glucagon Like Peptide 2 Receptor Sales Quantity (2019-2030)
        1.5.3 Global Glucagon Like Peptide 2 Receptor Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Hanmi Pharmaceuticals Co Ltd
        2.1.1 Hanmi Pharmaceuticals Co Ltd Details
        2.1.2 Hanmi Pharmaceuticals Co Ltd Major Business
        2.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product and Services
        2.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
    2.2 Naia Ltd
        2.2.1 Naia Ltd Details
        2.2.2 Naia Ltd Major Business
        2.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Product and Services
        2.2.4 Naia Ltd Glucagon Like Peptide 2 Receptor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Naia Ltd Recent Developments/Updates
    2.3 Takeda
        2.3.1 Takeda Details
        2.3.2 Takeda Major Business
        2.3.3 Takeda Glucagon Like Peptide 2 Receptor Product and Services
        2.3.4 Takeda Glucagon Like Peptide 2 Receptor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Takeda Recent Developments/Updates
    2.4 Tasly Pharmaceutical Group Co Ltd
        2.4.1 Tasly Pharmaceutical Group Co Ltd Details
        2.4.2 Tasly Pharmaceutical Group Co Ltd Major Business
        2.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product and Services
        2.4.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates
    2.5 Zealand Pharma AS
        2.5.1 Zealand Pharma AS Details
        2.5.2 Zealand Pharma AS Major Business
        2.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product and Services
        2.5.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Zealand Pharma AS Recent Developments/Updates

3 Competitive Environment: Glucagon Like Peptide 2 Receptor by Manufacturer
    3.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturer (2019-2024)
    3.3 Global Glucagon Like Peptide 2 Receptor Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Glucagon Like Peptide 2 Receptor by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Glucagon Like Peptide 2 Receptor Manufacturer Market Share in 2023
        3.4.2 Top 6 Glucagon Like Peptide 2 Receptor Manufacturer Market Share in 2023
    3.5 Glucagon Like Peptide 2 Receptor Market: Overall Company Footprint Analysis
        3.5.1 Glucagon Like Peptide 2 Receptor Market: Region Footprint
        3.5.2 Glucagon Like Peptide 2 Receptor Market: Company Product Type Footprint
        3.5.3 Glucagon Like Peptide 2 Receptor Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Glucagon Like Peptide 2 Receptor Market Size by Region
        4.1.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2019-2030)
        4.1.2 Global Glucagon Like Peptide 2 Receptor Consumption Value by Region (2019-2030)
        4.1.3 Global Glucagon Like Peptide 2 Receptor Average Price by Region (2019-2030)
    4.2 North America Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030)
    4.3 Europe Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030)
    4.4 Asia-Pacific Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030)
    4.5 South America Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030)
    4.6 Middle East and Africa Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2030)
    5.2 Global Glucagon Like Peptide 2 Receptor Consumption Value by Type (2019-2030)
    5.3 Global Glucagon Like Peptide 2 Receptor Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2030)
    6.2 Global Glucagon Like Peptide 2 Receptor Consumption Value by Application (2019-2030)
    6.3 Global Glucagon Like Peptide 2 Receptor Average Price by Application (2019-2030)

7 North America
    7.1 North America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2030)
    7.2 North America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2030)
    7.3 North America Glucagon Like Peptide 2 Receptor Market Size by Country
        7.3.1 North America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2019-2030)
        7.3.2 North America Glucagon Like Peptide 2 Receptor Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2030)
    8.2 Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2030)
    8.3 Europe Glucagon Like Peptide 2 Receptor Market Size by Country
        8.3.1 Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2019-2030)
        8.3.2 Europe Glucagon Like Peptide 2 Receptor Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size by Region
        9.3.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2030)
    10.2 South America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2030)
    10.3 South America Glucagon Like Peptide 2 Receptor Market Size by Country
        10.3.1 South America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2019-2030)
        10.3.2 South America Glucagon Like Peptide 2 Receptor Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Glucagon Like Peptide 2 Receptor Market Size by Country
        11.3.1 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Glucagon Like Peptide 2 Receptor Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Glucagon Like Peptide 2 Receptor Market Drivers
    12.2 Glucagon Like Peptide 2 Receptor Market Restraints
    12.3 Glucagon Like Peptide 2 Receptor Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Glucagon Like Peptide 2 Receptor and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Glucagon Like Peptide 2 Receptor
    13.3 Glucagon Like Peptide 2 Receptor Production Process
    13.4 Glucagon Like Peptide 2 Receptor Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Glucagon Like Peptide 2 Receptor Typical Distributors
    14.3 Glucagon Like Peptide 2 Receptor Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Glucagon Like Peptide 2 Receptor Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Glucagon Like Peptide 2 Receptor Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Hanmi Pharmaceuticals Co Ltd Basic Information, Manufacturing Base and Competitors
    Table 4. Hanmi Pharmaceuticals Co Ltd Major Business
    Table 5. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product and Services
    Table 6. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
    Table 8. Naia Ltd Basic Information, Manufacturing Base and Competitors
    Table 9. Naia Ltd Major Business
    Table 10. Naia Ltd Glucagon Like Peptide 2 Receptor Product and Services
    Table 11. Naia Ltd Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Naia Ltd Recent Developments/Updates
    Table 13. Takeda Basic Information, Manufacturing Base and Competitors
    Table 14. Takeda Major Business
    Table 15. Takeda Glucagon Like Peptide 2 Receptor Product and Services
    Table 16. Takeda Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Takeda Recent Developments/Updates
    Table 18. Tasly Pharmaceutical Group Co Ltd Basic Information, Manufacturing Base and Competitors
    Table 19. Tasly Pharmaceutical Group Co Ltd Major Business
    Table 20. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product and Services
    Table 21. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates
    Table 23. Zealand Pharma AS Basic Information, Manufacturing Base and Competitors
    Table 24. Zealand Pharma AS Major Business
    Table 25. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product and Services
    Table 26. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Zealand Pharma AS Recent Developments/Updates
    Table 28. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
    Table 29. Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 30. Global Glucagon Like Peptide 2 Receptor Average Price by Manufacturer (2019-2024) & (USD/Pcs)
    Table 31. Market Position of Manufacturers in Glucagon Like Peptide 2 Receptor, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 32. Head Office and Glucagon Like Peptide 2 Receptor Production Site of Key Manufacturer
    Table 33. Glucagon Like Peptide 2 Receptor Market: Company Product Type Footprint
    Table 34. Glucagon Like Peptide 2 Receptor Market: Company Product Application Footprint
    Table 35. Glucagon Like Peptide 2 Receptor New Market Entrants and Barriers to Market Entry
    Table 36. Glucagon Like Peptide 2 Receptor Mergers, Acquisition, Agreements, and Collaborations
    Table 37. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 38. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 39. Global Glucagon Like Peptide 2 Receptor Consumption Value by Region (2019-2024) & (USD Million)
    Table 40. Global Glucagon Like Peptide 2 Receptor Consumption Value by Region (2025-2030) & (USD Million)
    Table 41. Global Glucagon Like Peptide 2 Receptor Average Price by Region (2019-2024) & (USD/Pcs)
    Table 42. Global Glucagon Like Peptide 2 Receptor Average Price by Region (2025-2030) & (USD/Pcs)
    Table 43. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 44. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 45. Global Glucagon Like Peptide 2 Receptor Consumption Value by Type (2019-2024) & (USD Million)
    Table 46. Global Glucagon Like Peptide 2 Receptor Consumption Value by Type (2025-2030) & (USD Million)
    Table 47. Global Glucagon Like Peptide 2 Receptor Average Price by Type (2019-2024) & (USD/Pcs)
    Table 48. Global Glucagon Like Peptide 2 Receptor Average Price by Type (2025-2030) & (USD/Pcs)
    Table 49. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 50. Global Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 51. Global Glucagon Like Peptide 2 Receptor Consumption Value by Application (2019-2024) & (USD Million)
    Table 52. Global Glucagon Like Peptide 2 Receptor Consumption Value by Application (2025-2030) & (USD Million)
    Table 53. Global Glucagon Like Peptide 2 Receptor Average Price by Application (2019-2024) & (USD/Pcs)
    Table 54. Global Glucagon Like Peptide 2 Receptor Average Price by Application (2025-2030) & (USD/Pcs)
    Table 55. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 56. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 57. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 58. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 59. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 60. North America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 61. North America Glucagon Like Peptide 2 Receptor Consumption Value by Country (2019-2024) & (USD Million)
    Table 62. North America Glucagon Like Peptide 2 Receptor Consumption Value by Country (2025-2030) & (USD Million)
    Table 63. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 64. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 65. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 66. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 67. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 68. Europe Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 69. Europe Glucagon Like Peptide 2 Receptor Consumption Value by Country (2019-2024) & (USD Million)
    Table 70. Europe Glucagon Like Peptide 2 Receptor Consumption Value by Country (2025-2030) & (USD Million)
    Table 71. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 72. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 73. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 74. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 75. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 76. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 77. Asia-Pacific Glucagon Like Peptide 2 Receptor Consumption Value by Region (2019-2024) & (USD Million)
    Table 78. Asia-Pacific Glucagon Like Peptide 2 Receptor Consumption Value by Region (2025-2030) & (USD Million)
    Table 79. South America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 80. South America Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 81. South America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 82. South America Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 83. South America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 84. South America Glucagon Like Peptide 2 Receptor Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 85. South America Glucagon Like Peptide 2 Receptor Consumption Value by Country (2019-2024) & (USD Million)
    Table 86. South America Glucagon Like Peptide 2 Receptor Consumption Value by Country (2025-2030) & (USD Million)
    Table 87. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 88. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 89. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 90. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 91. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 92. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 93. Middle East & Africa Glucagon Like Peptide 2 Receptor Consumption Value by Region (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Glucagon Like Peptide 2 Receptor Consumption Value by Region (2025-2030) & (USD Million)
    Table 95. Glucagon Like Peptide 2 Receptor Raw Material
    Table 96. Key Manufacturers of Glucagon Like Peptide 2 Receptor Raw Materials
    Table 97. Glucagon Like Peptide 2 Receptor Typical Distributors
    Table 98. Glucagon Like Peptide 2 Receptor Typical Customers
List of Figures
    Figure 1. Glucagon Like Peptide 2 Receptor Picture
    Figure 2. Global Glucagon Like Peptide 2 Receptor Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Type in 2023
    Figure 4. FE-203799 Examples
    Figure 5. Glepaglutide Examples
    Figure 6. GXG-8 Examples
    Figure 7. HM-15910 Examples
    Figure 8. Others Examples
    Figure 9. Global Glucagon Like Peptide 2 Receptor Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 10. Global Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Application in 2023
    Figure 11. Short Bowel Syndrome Examples
    Figure 12. Diabetes Examples
    Figure 13. Diarrhea Examples
    Figure 14. Obesity Examples
    Figure 15. Others Examples
    Figure 16. Global Glucagon Like Peptide 2 Receptor Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 17. Global Glucagon Like Peptide 2 Receptor Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 18. Global Glucagon Like Peptide 2 Receptor Sales Quantity (2019-2030) & (K Pcs)
    Figure 19. Global Glucagon Like Peptide 2 Receptor Average Price (2019-2030) & (USD/Pcs)
    Figure 20. Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Manufacturer in 2023
    Figure 21. Global Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Manufacturer in 2023
    Figure 22. Producer Shipments of Glucagon Like Peptide 2 Receptor by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 23. Top 3 Glucagon Like Peptide 2 Receptor Manufacturer (Consumption Value) Market Share in 2023
    Figure 24. Top 6 Glucagon Like Peptide 2 Receptor Manufacturer (Consumption Value) Market Share in 2023
    Figure 25. Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Region (2019-2030)
    Figure 26. Global Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Region (2019-2030)
    Figure 27. North America Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030) & (USD Million)
    Figure 28. Europe Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030) & (USD Million)
    Figure 29. Asia-Pacific Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030) & (USD Million)
    Figure 30. South America Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030) & (USD Million)
    Figure 31. Middle East & Africa Glucagon Like Peptide 2 Receptor Consumption Value (2019-2030) & (USD Million)
    Figure 32. Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2019-2030)
    Figure 33. Global Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Type (2019-2030)
    Figure 34. Global Glucagon Like Peptide 2 Receptor Average Price by Type (2019-2030) & (USD/Pcs)
    Figure 35. Global Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2019-2030)
    Figure 36. Global Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Application (2019-2030)
    Figure 37. Global Glucagon Like Peptide 2 Receptor Average Price by Application (2019-2030) & (USD/Pcs)
    Figure 38. North America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2019-2030)
    Figure 39. North America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2019-2030)
    Figure 40. North America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Country (2019-2030)
    Figure 41. North America Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Country (2019-2030)
    Figure 42. United States Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 43. Canada Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. Mexico Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. Europe Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2019-2030)
    Figure 46. Europe Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2019-2030)
    Figure 47. Europe Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Country (2019-2030)
    Figure 48. Europe Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Country (2019-2030)
    Figure 49. Germany Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. France Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. United Kingdom Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. Russia Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Italy Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2019-2030)
    Figure 55. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2019-2030)
    Figure 56. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Region (2019-2030)
    Figure 57. Asia-Pacific Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Region (2019-2030)
    Figure 58. China Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Japan Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Korea Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. India Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. Southeast Asia Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Australia Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. South America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2019-2030)
    Figure 65. South America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2019-2030)
    Figure 66. South America Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Country (2019-2030)
    Figure 67. South America Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Country (2019-2030)
    Figure 68. Brazil Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Argentina Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Type (2019-2030)
    Figure 71. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Application (2019-2030)
    Figure 72. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Quantity Market Share by Region (2019-2030)
    Figure 73. Middle East & Africa Glucagon Like Peptide 2 Receptor Consumption Value Market Share by Region (2019-2030)
    Figure 74. Turkey Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Egypt Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Saudi Arabia Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 77. South Africa Glucagon Like Peptide 2 Receptor Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 78. Glucagon Like Peptide 2 Receptor Market Drivers
    Figure 79. Glucagon Like Peptide 2 Receptor Market Restraints
    Figure 80. Glucagon Like Peptide 2 Receptor Market Trends
    Figure 81. Porters Five Forces Analysis
    Figure 82. Manufacturing Cost Structure Analysis of Glucagon Like Peptide 2 Receptor in 2023
    Figure 83. Manufacturing Process Analysis of Glucagon Like Peptide 2 Receptor
    Figure 84. Glucagon Like Peptide 2 Receptor Industrial Chain
    Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 86. Direct Channel Pros & Cons
    Figure 87. Indirect Channel Pros & Cons
    Figure 88. Methodology
    Figure 89. Research Process and Data Source

Companies Mentioned

Hanmi Pharmaceuticals Co Ltd
Naia Ltd
Takeda
Tasly Pharmaceutical Group Co Ltd
Zealand Pharma AS